206 related articles for article (PubMed ID: 9411736)
21. Comparison of perioperative versus postoperative intratumoral administration of cisplatin for treatment of cutaneous sarcoids and squamous cell carcinomas in horses.
Théon AP; Pascoe JR; Galuppo LD; Fisher PE; Griffey SM; Madigan JE
J Am Vet Med Assoc; 1999 Dec; 215(11):1655-60. PubMed ID: 14567430
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy of equine sarcoid: dose-escalation trial for the use of chimeric papillomavirus-like particles.
Mattil-Fritz S; Scharner D; Piuko K; Thönes N; Gissmann L; Müller H; Müller M
J Gen Virol; 2008 Jan; 89(Pt 1):138-147. PubMed ID: 18089737
[TBL] [Abstract][Full Text] [Related]
23. A novel murine model for evaluating bovine papillomavirus prophylactics/therapeutics for equine sarcoid-like tumours.
Bogaert L; Woodham AW; Da Silva DM; Martens A; Meyer E; Kast WM
J Gen Virol; 2015 Sep; 96(9):2764-2768. PubMed ID: 26044793
[TBL] [Abstract][Full Text] [Related]
24. Autologous vaccination for the treatment of equine sarcoids: 18 cases (2009-2014).
Rothacker CC; Boyle AG; Levine DG
Can Vet J; 2015 Jul; 56(7):709-14. PubMed ID: 26130832
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with the risk of developing sarcoid tumours in horses.
Mohammed HO; Rebhun WC; Antczak DF
Equine Vet J; 1992 May; 24(3):165-8. PubMed ID: 1606927
[TBL] [Abstract][Full Text] [Related]
26. Sarcoid in horses.
Strafuss AC; Smith JE; Dennis SM; Anthony HD
Vet Med Small Anim Clin; 1973 Nov; 68(11):1246-7. PubMed ID: 4491121
[No Abstract] [Full Text] [Related]
27. Immunogenicity analysis of BPV-1 positive equine sarcoid-derived cultured fibroblasts.
Gysens L; Depuydt E; Patruno M; Haspeslagh M; Spaas JH; Martens A
Vet Immunol Immunopathol; 2023 Feb; 256():110547. PubMed ID: 36621059
[TBL] [Abstract][Full Text] [Related]
28. Equine skin tumours in 20 horses resembling three variants of human melanocytic naevi.
Schöniger S; Summers BA
Vet Dermatol; 2009 Jun; 20(3):165-73. PubMed ID: 19374725
[TBL] [Abstract][Full Text] [Related]
29. Equine leucocyte antigens in sarcoid-affected horses.
Lazary S; Gerber H; Glatt PA; Straub R
Equine Vet J; 1985 Jul; 17(4):283-6. PubMed ID: 3865769
[TBL] [Abstract][Full Text] [Related]
30. The use of Baypamun N in crowding associated infectious respiratory disease: efficacy of Baypamun N (freeze dried product) in 4-10 month old horses.
Ziebell KL; Steinmann H; Kretzdorn D; Schlapp T; Failing K; Schmeer N
Zentralbl Veterinarmed B; 1997 Nov; 44(9):529-36. PubMed ID: 9451942
[TBL] [Abstract][Full Text] [Related]
31. Experimental treatment of equine sarcoid using a xanthate compound and recombinant human tumour necrosis factor alpha.
Otten N; Marti E; Söderström C; Amtmann E; Burger D; Gerber H; Lazary S
Zentralbl Veterinarmed A; 1994 Dec; 41(10):757-65. PubMed ID: 7653114
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and prognostic potential of eight whole blood microRNAs for equine sarcoid disease.
Cosandey J; Hamza E; Gerber V; Ramseyer A; Leeb T; Jagannathan V; Blaszczyk K; Unger L
PLoS One; 2021; 16(12):e0261076. PubMed ID: 34941894
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of equine sarcoids with cisplatin in arachid oil: a useful alternative?].
Spoormakers TJ; Klein WR; van Weeren PR
Tijdschr Diergeneeskd; 2002 Jun; 127(11):350-4. PubMed ID: 12073779
[TBL] [Abstract][Full Text] [Related]
34. Electrochemotherapy as a single or adjuvant treatment to surgery of cutaneous sarcoid tumours in horses: a 31-case retrospective study.
Tozon N; Kramaric P; Kos Kadunc V; Sersa G; Cemazar M
Vet Rec; 2016 Dec; 179(24):627. PubMed ID: 27758950
[TBL] [Abstract][Full Text] [Related]
35. Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (Viscum album austriacus).
Christen-Clottu O; Klocke P; Burger D; Straub R; Gerber V
J Vet Intern Med; 2010; 24(6):1483-9. PubMed ID: 21039860
[TBL] [Abstract][Full Text] [Related]
36. Treatment of equine sarcoids.
Winston T; Rings M; Wyman M
J Am Vet Med Assoc; 1979 Oct; 175(8):775. PubMed ID: 528320
[No Abstract] [Full Text] [Related]
37. Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids.
Yuan ZQ; Gault EA; Gobeil P; Nixon C; Campo MS; Nasir L
Virology; 2008 Apr; 373(2):352-61. PubMed ID: 18191170
[TBL] [Abstract][Full Text] [Related]
38. Histopathological characteristics of five clinical types of equine sarcoid.
Martens A; De Moor A; Demeulemeester J; Ducatelle R
Res Vet Sci; 2000 Dec; 69(3):295-300. PubMed ID: 11124103
[TBL] [Abstract][Full Text] [Related]
39. Activated platelet-derived growth factor beta receptor expression, PI3K-AKT pathway molecular analysis, and transforming signals in equine sarcoids.
Borzacchiello G; Mogavero S; De Vita G; Roperto S; Della Salda L; Roperto F
Vet Pathol; 2009 Jul; 46(4):589-97. PubMed ID: 19276057
[TBL] [Abstract][Full Text] [Related]
40. Treatment of equine sarcoids using recombinant poxviruses expressing feline interleukin-2.
Loschelder-Ostrowski J; Winter JC; Merle R; Klopfleisch R; Gehlen H
Vet Dermatol; 2021 Jun; 32(3):283-e77. PubMed ID: 33728715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
